Impact of Genetic Risk Assessment on Nutrition-related Lifestyle Behaviours

Overview

Journal Proc Nutr Soc

Specialty Nutritional Sciences

Date 2012 Oct 26

PMID 23095764

Citations 8

Authors

Jacqueline A Vernarelli

Affiliations

Soon will be listed here.

Abstract

Genetic susceptibility testing for common complex disease is a practice that is currently in clinical use. There are two types of gene mutations, and therefore, two varieties of genotype testing: deterministic and susceptibility. As the term suggests, deterministic genes determine whether or not a person will develop a given trait in mendelian fashion, such as Huntington's disease. Genotype screening for such deterministic mutations has existed for decades, and is commonly used in routine medical practice. In recent years, the sequencing of the human genome has identified several 'susceptibility genes' or genes with incomplete penetrance. Mutations in these genes may increase disease susceptibility, but are not causative for disease. Genetic susceptibility testing allows unaffected individuals to obtain risk information for a variety of common complex diseases and health conditions including Alzheimer's disease (AD), CVD, cancer and diabetes. The availability of genetic susceptibility testing has increased over the past decade, and several studies are now focusing on the impact that genetic testing has on health and other lifestyle behaviours related to nutrition. The aim of this paper is to review the literature and evaluate what, if any, impact genetic risk assessment has on behaviours related to nutrition and physical activity. This paper summarises seven clinical studies that evaluated the impact of disclosing genetic risk information for disease on nutrition-related health behaviour changes. Of these seven studies, only three studies reported that health behaviour change was influenced by genotype disclosure.

Citing Articles

People's interest in brain health testing: Findings from an international, online cross-sectional survey.

Carver R, Fredheim N, Mowinckel A, Ebmeier K, Friedman B, Rosness T Front Public Health. 2022; 10:998302.

PMID: 36339192 PMC: 9631023. DOI: 10.3389/fpubh.2022.998302.

Are People Ready for Personalized Brain Health? Perspectives of Research Participants in the Lifebrain Consortium.

Friedman B, Suri S, Sole-Padulles C, Duzel S, Drevon C, Baare W Gerontologist. 2019; 60(6):1050-1059.

PMID: 31682729 PMC: 7427479. DOI: 10.1093/geront/gnz155.

Self-efficacy and self-management strategies in acute intermittent porphyria.

Hammersland M, Aarsand A, Sandberg S, Andersen J BMC Health Serv Res. 2019; 19(1):444.

PMID: 31269991 PMC: 6607542. DOI: 10.1186/s12913-019-4285-9.

Communication of cancer-related genetic and genomic information: A landscape analysis of reviews.

Peterson E, Chou W, Gaysynsky A, Krakow M, Elrick A, Khoury M Transl Behav Med. 2018; 8(1):59-70.

PMID: 29385592 PMC: 6065548. DOI: 10.1093/tbm/ibx063.

The Alzheimer's Prevention Clinic at Weill Cornell Medical College / New York - Presbyterian Hospital: Risk Stratification and Personalized Early Intervention.

Seifan A, Isaacson R J Prev Alzheimers Dis. 2017; 2(4):254-266.

PMID: 28529933 PMC: 5434764. DOI: 10.14283/jpad.2015.81.

References

Solomon C, Pho L, Burt R . Current status of genetic testing for colorectal cancer susceptibility. Oncology (Williston Park). 2002; 16(2):161-71; discussion 176, 179-80. View

Roberts J, Tersegno S . Estimating and disclosing the risk of developing Alzheimer's disease: challenges, controversies and future directions. Future Neurol. 2010; 5(4):501-517. PMC: 2941213. DOI: 10.2217/fnl.10.31. View

Vernarelli J, Roberts J, Hiraki S, Chen C, Cupples L, Green R . Effect of Alzheimer disease genetic risk disclosure on dietary supplement use. Am J Clin Nutr. 2010; 91(5):1402-7. PMC: 2854909. DOI: 10.3945/ajcn.2009.28981. View

Schwartz M, Isaacs C, Graves K, Poggi E, Peshkin B, Gell C . Long-term outcomes of BRCA1/BRCA2 testing: risk reduction and surveillance. Cancer. 2011; 118(2):510-7. PMC: 3286617. DOI: 10.1002/cncr.26294. View

Yokoyama A, Omori T . Genetic polymorphisms of alcohol and aldehyde dehydrogenases and risk for esophageal and head and neck cancers. Jpn J Clin Oncol. 2003; 33(3):111-21. DOI: 10.1093/jjco/hyg026. View

Carpenter M, Alberg A, Gray K, Saladin M . Motivating the unmotivated for health behavior change: a randomized trial of cessation induction for smokers. Clin Trials. 2010; 7(2):157-66. PMC: 2902976. DOI: 10.1177/1740774510361533. View

Reichenbach S, Juni P . Medical food and food supplements: not always as safe as generally assumed. Ann Intern Med. 2012; 156(12):894-5, W314. DOI: 10.7326/0003-4819-156-12-201206190-00012. View

Strange C, Dickson R, Carter C, Carpenter M, Holladay B, Lundquist R . Genetic testing for alpha1-antitrypsin deficiency. Genet Med. 2004; 6(4):204-10. DOI: 10.1097/01.gim.0000132669.09819.79. View

Taylor J, Wu C . Effects of genetic counseling for hypertension on changes in lifestyle behaviors among African-American women. J Natl Black Nurses Assoc. 2009; 20(1):1-10. PMC: 2877127. View

10.

Phillips K, Jenkins M, Lindeman G, McLachlan S, McKinley J, Weideman P . Risk-reducing surgery, screening and chemoprevention practices of BRCA1 and BRCA2 mutation carriers: a prospective cohort study. Clin Genet. 2006; 70(3):198-206. DOI: 10.1111/j.1399-0004.2006.00665.x. View

11.

ONeill S, Valdimarsdottir H, DeMarco T, Peshkin B, Graves K, Brown K . BRCA1/2 test results impact risk management attitudes, intentions, and uptake. Breast Cancer Res Treat. 2010; 124(3):755-64. PMC: 3039480. DOI: 10.1007/s10549-010-0881-4. View

12.

Peng S, Zhu Y, Xu F, Ren X, Li X, Lai M . FTO gene polymorphisms and obesity risk: a meta-analysis. BMC Med. 2011; 9:71. PMC: 3118373. DOI: 10.1186/1741-7015-9-71. View

13.

Nichter M, Thompson J . For my wellness, not just my illness: North Americans' use of dietary supplements. Cult Med Psychiatry. 2006; 30(2):175-222. DOI: 10.1007/s11013-006-9016-0. View

14.

Metcalfe K, Birenbaum-Carmeli D, Lubinski J, Gronwald J, Lynch H, Moller P . International variation in rates of uptake of preventive options in BRCA1 and BRCA2 mutation carriers. Int J Cancer. 2008; 122(9):2017-22. PMC: 2936778. DOI: 10.1002/ijc.23340. View

15.

Cupples L, Farrer L, Sadovnick A, Relkin N, Whitehouse P, Green R . Estimating risk curves for first-degree relatives of patients with Alzheimer's disease: the REVEAL study. Genet Med. 2004; 6(4):192-6. DOI: 10.1097/01.gim.0000132679.92238.58. View

16.

ONeill S, Kaufman E, DeMarco T, Peshkin B, McKenna K, Shelby R . Changes in diet and physical activity following BRCA1/2 testing. J Psychosoc Oncol. 2008; 26(3):63-80. DOI: 10.1080/07347330802116051. View

17.

Scuteri A, Sanna S, Chen W, Uda M, Albai G, Strait J . Genome-wide association scan shows genetic variants in the FTO gene are associated with obesity-related traits. PLoS Genet. 2007; 3(7):e115. PMC: 1934391. DOI: 10.1371/journal.pgen.0030115. View

18.

Rosenstock I . Why people use health services. Milbank Mem Fund Q. 1966; 44(3):Suppl:94-127. View

19.

Chao S, Roberts J, Marteau T, Silliman R, Cupples L, Green R . Health behavior changes after genetic risk assessment for Alzheimer disease: The REVEAL Study. Alzheimer Dis Assoc Disord. 2008; 22(1):94-7. PMC: 2483341. DOI: 10.1097/WAD.0b013e31815a9dcc. View

20.

Loos R, Bouchard C . FTO: the first gene contributing to common forms of human obesity. Obes Rev. 2008; 9(3):246-50. DOI: 10.1111/j.1467-789X.2008.00481.x. View